Singular Genomics Systems... (OMIC)
NASDAQ: OMIC
· Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM
Singular Genomics Systems Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -86.32M | -91.89M | -96.21M | -94.82M | -92.67M | -94.1M | -92.51M | -90.88M | -89.54M | -83.36M | -96.86M | -98.77M | -86.92M | -77.25M | -46.61M |
Depreciation & Amortization | 6.85M | 7.03M | 7.13M | 7.22M | 7.29M | 7.09M | 6.75M | 6.03M | 4.67M | 3.31M | 2.02M | 1.13M | 967K | 835K | 719K |
Stock-Based Compensation | 9.93M | 10.56M | 11.22M | 11.4M | 11.82M | 12.42M | 13.18M | 13.67M | 13.51M | 12.96M | 11.7M | 9.23M | 6.59M | 4M | 1.92M |
Other Working Capital | -6.76M | 393K | -475K | 1.24M | 902K | 946K | 209K | -1.25M | -1.1M | -1.25M | -5.71M | -4.76M | -4.43M | -5.39M | 545K |
Other Non-Cash Items | 6.78M | 10.28M | 10.52M | 5.34M | 2.02M | 655K | 1.05M | 901K | 2.19M | 1.76M | 25.21M | 35.48M | 35.52M | 35.49M | 11.68M |
Deferred Income Tax | -1.07M | -2.18M | -545K | -545K | 527K | 1.63M | n/a | n/a | 501K | 1.42M | 1.86M | 4.14M | 3.8M | 2.96M | 2.53M |
Change in Working Capital | -9.33M | -4M | -4.27M | -2.25M | -3.64M | -7.33M | -13.67M | -16.82M | -14.21M | -8.16M | -6.3M | -2.91M | -2.93M | -4.71M | 413K |
Operating Cash Flow | -80.43M | -77.46M | -79.42M | -73.65M | -74.66M | -79.64M | -85.19M | -87.09M | -82.88M | -72.07M | -62.35M | -51.7M | -42.99M | -38.68M | -29.35M |
Capital Expenditures | -425K | -528K | -833K | -970K | -2.4M | -3.41M | -5.25M | -6.02M | -5.97M | -6.47M | -5.3M | -4.86M | -3.33M | -2.43M | -1.63M |
Cash Acquisitions | 38.33M | 38.33M | 73.11M | n/a | -40.32M | -3.33M | -30.24M | 42.87M | 44.86M | 7.87M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -92.35M | -126.2M | -195.76M | -183.59M | -164.6M | -204.82M | -146.54M | -174.71M | -188.82M | -138.17M | -129.27M | -195.68M | -146.06M | -126.69M | -105.65M |
Sales Maturities Of Investments | 191.26M | 158.22M | 169.03M | 198.37M | 180.32M | 208.15M | 176.78M | 141.17M | 131.74M | 113.98M | 102.55M | 69.69M | 49.51M | 41.5M | 38.42M |
Other Investing Acitivies | -38.33M | -38.33M | -73.11M | n/a | 40.32M | 3.33M | 30.24M | -33.54M | -57.09M | -24.19M | -26.72M | -126M | -96.55M | -85.19M | -67.23M |
Investing Cash Flow | 98.49M | 31.49M | -27.56M | 13.81M | 13.33M | -87K | 24.99M | -39.57M | -63.06M | -30.65M | -32.01M | -130.86M | -99.88M | -87.63M | -68.85M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 100K | 130.6M | 130.6M | 130.5M | 130.5M |
Common Stock Repurchased | 74K | -6K | -12K | -19K | -463K | -369K | -784K | -788K | -338K | -1.85M | -1.43M | -1.42M | -1.42M | 10K | 10K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13K | 158K | 696K | 709K | 1.83M | 1.86M | 1.33M | 1.35M | -2.62M | -2.62M | 786K | 752K | 3.5M | 3.45M | -32K |
Financial Cash Flow | 152K | 152K | 690K | 696K | 1.37M | 1.4M | 884K | 901K | 961K | -386K | 238.67M | 372.13M | 371.35M | 372.64M | 133.49M |
Net Cash Flow | 18.81M | -45.81M | -106.28M | -59.14M | -59.96M | -78.32M | -59.31M | -125.76M | -144.98M | -103.11M | 144.3M | 189.57M | 228.48M | 246.34M | 35.29M |
Free Cash Flow | -80.86M | -77.98M | -80.25M | -74.62M | -77.06M | -83.05M | -90.43M | -93.12M | -88.85M | -78.53M | -67.65M | -56.56M | -46.32M | -41.11M | -30.98M |